Identifying postelimination trends for the introduction and transmissibility of measles in the United States

American Journal of Epidemiology

Volumn 179, Issue 11, 2014, Pages 1375-1382

  Blumberg, Seth ^a,b   Enanoria, Wayne T A ^a,c   Lloyd Smith, James O ^b,d   Lietman, Thomas M ^a,e   Porco, Travis C ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

disease elimination; effective reproduction number; heterogeneity of transmission; measles; preventable disease; transmissibility; United States; vaccine coverage

Indexed keywords

DISEASE CONTROL; DISEASE INCIDENCE; DISEASE TRANSMISSION; EPIDEMIOLOGY; MEASLES; PATHOGEN; VACCINE;

ARTICLE; DISEASE ELIMINATION; DISEASE TRANSMISSION; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; HUMAN; MEASLES; TREND STUDY; UNITED STATES;

UNITED STATES;

DISEASE ELIMINATION; EFFECTIVE REPRODUCTION NUMBER; HETEROGENEITY OF TRANSMISSION; MEASLES; PREVENTABLE DISEASE; TRANSMISSIBILITY; UNITED STATES; VACCINE COVERAGE;

BINOMIAL DISTRIBUTION; DISEASE ERADICATION; DISEASE OUTBREAKS; HUMANS; LIKELIHOOD FUNCTIONS; MEASLES; MODELS, STATISTICAL; PUBLIC HEALTH SURVEILLANCE; REGRESSION ANALYSIS; UNITED STATES; VACCINATION;

EID: 84901701248     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu068     Document Type: Article

References (27)

1. World Health Organization. Global eradication of measles: report by the Secretariat. 2010. http://www.who.int/iris/handle/10665/2387. Published March 25, 2010. Accessed November 9, 2013.
2. Grabowsky M. The beginning of the end of measles and rubella. JAMA Pediatr. 2014;168(2):108-109.
3. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis. 2004; 189(suppl 1):S43-S47. (Pubitemid 38639567)
4. Papania MJ, Orenstein WA. Defining and assessing measles elimination goals. J Infect Dis. 2004;189(suppl 1):S23-S26. (Pubitemid 38639564)
5. Gay NJ, De Serres G, Farrington CP, et al. Assessment of the status of measles elimination from reported outbreaks: United States, 1997-1999. J Infect Dis. 2004;189(suppl 1):S36-S42. (Pubitemid 38639566)
6. Parker Fiebelkorn A, Redd SB, Gallagher K, et al. Measles in the United States during the postelimination era. J Infect Dis. 2010;202(10):1520-1528.
7. Jansen VAA, Stollenwerk N, Jensen HJ, et al. Measles outbreaks in a population with declining vaccine uptake. Science. 2003;301(5634):804. (Pubitemid 36962614)
8. Omer SB, Salmon DA, Orenstein WA, et al. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360(19):1981-1988.
9. Centers for Disease Control and Prevention. Documentation and verification of measles, rubella and congenital rubella syndrome elimination in the region of the Americas. United States National Report, March 28, 2012. Posted October, 2012.
10. http://www.cdc.gov/measles/stats-surv.html. Accessed September 23, 2013.
11. Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the western hemisphere: the US experience. JAMA Pediatr. 2014;168(2):148-155.
12. De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol. 2000; 151(11):1039-1048. (Pubitemid 30489197)
13. McQuillan GM, Kruszon-Moran D, Hyde TB, et al. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis. 2007;196(10):1459-1464. (Pubitemid 351411981)
14. Black CL, Wooten KG, Yankey D, et al. National and state vaccination coverage among children aged 19-35 months-United States, 2010. Morb Mortal Wkly Rep. 2011;60(34): 1157-1163.
15. Lloyd-Smith JO, Schreiber SJ, Kopp PE, et al. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355-359. (Pubitemid 41643951)
16. 0 from the size distribution of subcritical transmission chains. Epidemics. 2013;5(3):131-145.
17. 0 and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput Biol. 2013;9(5):e1002993.
18. Harpaz R, Papania MJ, McCauley MM, et al. Has surveillance been adequate to detect endemic measles in the United States? J Infect Dis. 2004;189(suppl 1):S191-S195. (Pubitemid 38639589)
19. Ferguson NM, Fraser C, Donnelly CA, et al. Public health risk from the avian H5N1 influenza epidemic. Science. 2004; 304(5673):968-969. (Pubitemid 38638081)
20. Nishiura H, Yan P, Sleeman CK, et al. Estimating the transmission potential of supercritical processes based on the final size distribution of minor outbreaks. J Theor Biol. 2012; 294:48-55.
21. Bolker BM. Ecological Models and Data in R. Princeton, NJ: Princeton University Press; 2008; 408 pp.
22. Mann HB. Nonparametric tests against trend. Econometrica. 1945;13(3):245-259.
23. Stokley S, Stanwyck C, Avey B, et al. Vaccination coverage among children in Kindergarten-United States, 2009-10 school year. Morb Mortal Wkly Rep. 2011;60(21):700-704.
24. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005;353(10):1008-1020. (Pubitemid 41262335)
25. van Boven M, Koopmans M, Du Ry van Beest Holle M, et al. Detecting emerging transmissibility of avian influenza virus in human households. PLoS Comput Biol. 2007;3(7): e145.
26. Minor PD. Polio vaccines and the eradication of poliomyelitis. Lancet. 2012;380(9840):454-455.
27. O'Reilly KM, Durry E, ul Islam O, et al. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet. 2012;380(9840): 491-498.